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Abstract Although a broad array of neurocognitive dysfunc-
tions are associated with ADHD, it is unknown whether these
dysfunctions play a role in the course of ADHD symptoms.
The present longitudinal study investigated whether
neurocognitive functions assessed at study-entry (mean
age = 11.5 years, SD = 2.7) predicted ADHD symptom sever-
ity and overall functioning 6 years later (mean age =17.4 years,
82.6 % = male) in a carefully phenotyped large sample of 226
Caucasian participants from 182 families diagnosed with
ADHD-combined type. Outcome measures were dimensional
measures of ADHD symptom severity and the Kiddie-Global
Assessment Scale (K-GAS) for overall functioning. Predictors
were derived from component scores for 8 domains of
neurocognitive functioning: working memory, motor inhibi-
tion, cognitive inhibition, reaction time variability, timing, in-
formation processing speed, motor control, intelligence.
Effects of age, gender, and pharmacological treatment were
considered. Results showed that better working memory pre-
dicted lower ADHD symptom severity (R2 = 3.0 %), and less
reaction time variability predicted better overall functioning
(higher K-GAS-score, R2 = 5.6 %). Predictors were still sig-
nificant with baseline behavior included in the models. The
role of neurocognitive functioning in the long term outcome
of ADHD behavior is discussed.
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Attention-Deficit/Hyperactivity Disorder (ADHD) is a com-
mon developmental disorder, with impairing and highly per-
sistent symptoms of inattention and/or hyperactivity/impulsiv-
ity (Biederman et al. 2011). Impairment exists in several do-
mains of functioning, including academic, social, and occupa-
tion functioning (Barkley et al. 2006). Patients with persistent
ADHD experience chronic problems in adult life compared to
those with remitted ADHD, such as higher rates of substance
use disorders (Klein et al. 2012) and other psychiatric comor-
bidities (Barbaresi et al. 2013). It is important to elucidate
factors involved in the course of ADHD, since ‘baseline’ pre-
dictors that would allow prediction of the course of ADHD in
terms of ADHD symptom severity and overall functioning
could be used to inform parents and children. Such informa-
tion may also guide further study into treatment; for example
investigating whether neurocognitive training of a particular
predictive function might enhance prognosis.
Neurocognitive functioning may act as predictor of symp-
tom severity and overall functioning of ADHD, as
neurocognitive dysfunction is a key aspect of the disorder
(Willcutt et al. 2008) and is at the heart of several models of
ADHD (Barkley 1997; Sergeant 2000; Sonuga-Barke et al.
2010). The relevance of neurocognitive functioning for the
course of ADHD has been emphasized by Halperin and
Schulz (2006). According to their model, higher-order mental
functions (so-called cognitive control functions as inhibition
and working memory) may contribute to better outcome.
To evaluate the hypothesis that neurocognitive functioning
may act as a predictor for ADHD outcome, we recently
reviewed existing literature. Some of the studies showed pos-
i t ive associat ions between concurrently assessed
neurocognitive performance and ADHD outcome in adoles-
cents (Barkley and Fischer 2011; Coghill et al. 2014; Halperin
et al. 2008). However, as baseline measures of neurocognitive
performance were not available in most of these studies, it
remains unknown whether the associations were apparent ear-
lier in childhood yet. On the basis of six studies that investi-
gated the predictive value of early assessed neurocognitive
functions, we concluded that ADHD symptom remission
was not predicted by neurocognitive functioning (van
Lieshout et al. 2013). This conclusion was largely supported
by more recent studies. One study showed that only one out of
nine neurocognitive functions (attentional set-shifting) pre-
dicted greater decrease in ADHD symptoms 10 years later
(Coghill et al. 2014). In addition, recent work has shown that
neurocognitive functions in childhood were not related to
ADHD outcome in adolescence (McAuley et al. 2014), and
that neurocognitive functions in 3-to-4 year olds were not
related to changes in ADHD severity 4.5 years later
(Rajendran et al. 2013a, b). One study showed that an aggre-
gated measure of neurocognitive functioning was related to
ADHD severity 1 year later in children between 5 and 7 years
but not in children between 4 and 5 years: better functioning
predicted lower ADHD severity (Rajendran et al. 2013a, b).
Finally, in one study that assessed ADHD symptoms, two out
of four neurocognitive measures (working memory and reac-
tion time variability) in preschool predicted future symptoms
of inattention (Sjöwall et al. 2015). Taken together, there is
only little evidence to predict ADHD outcomes based on early
neurocognitive functions.
However, these findings may be related to limitations of the
available literature. The first limitation is related to the type of
outcomemeasure chosen. Available studies have focusedmain-
ly on dichotomous outcomes (diagnosis yes/no), rather than on
more sensitive continuous measures of symptom severity
(Lahey and Willcutt 2010; Willcutt et al. 2012). Also, some
studies exclusively focused on ADHD core symptoms and
did not assess accompanying levels of impairment. Outcome
as measured in terms of the level of overall functioning may
clinically be more relevant. The second limitation relates to the
type of neurocognitive assessment used. Only few studies were
conducted on key neurocognitive functions associated with
ADHD, such as cognitive control, temporal processing and
reward processing (van Lieshout et al. 2013). Also, most of
the longitudinal studies did not consider a full set of
neurocognitive predictors together, which is important as pre-
dictors may overlap. Focusing on one domain also narrows
clinical applicability. In addition, not many studies investigated
whether early neurocognitive functions predict outcomes over
and above ADHD behavior, which is of importance to rule out
the possibility that neurocognitive functions act simply as a
proxy for ADHD severity. Fifth, most studies have not investi-
gated developmental and gender effects. Regarding develop-
mental effects, it is thought that development of an individual
is ongoing from childhood into adulthood with a sharp transi-
tion period in adolescence (Geier 2013). Also, neurocognitive
development is likely to be non-linear (Vaughn et al. 2011).
Therefore, it is important to consider moderating effects of
age when investigating outcomes over time. Previous studies
so far investigated a narrow age range or did not specifically
investigate possible moderating effects of age. For example,
only in very young children (3 to 6 years), neurocognitive
functioning predicted ADHD status or severity several years
later (Rajendran et al. 2013a, b; van Lieshout et al. 2013).
Also, it is possible that gender might impact on results, given
differences in brain structure and function in healthy controls
(Bell et al. 2006), and that prevalence rates of ADHD are higher
in males than in females (Willcutt 2012). Finally, few studies
took effects of pharmacological treatment into account. This
may be of importance, as pharmacological treatment may im-
pact on outcomes; for example, in a meta-analysis including 23
studies, it was found that both amphetamine and methylpheni-
date products were efficacious in treating ADHD symptoms
(Faraone and Buitelaar 2010).
The current study addressed the abovementioned issues by
employing a dimensional approach to investigate the
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predictive value of neurocognitive functioning for (1) ADHD
symptom severity and (2) overall functioning, using a longi-
tudinal design with a 6-year follow-up of children with
combined-type ADHD (ADHD/C). We investigated children
in the full range of childhood age, with careful consideration
of age-dependent effects. As ADHD is associated with hetero-
geneity in neurocognitive deficits (Nigg et al. 2005), we
assessed a broad array of neurocognitive functions to capture
as much as possible this heterogeneity. We used measures of
cognitive control (motor inhibition, cognitive inhibition,
working memory) and temporal processing (variability in
responding, timing), as well as other functions that show im-
pairments in individuals with ADHD (basic information pro-
cessing speed, motor control, and intellectual functioning). In
addition, neurocognitive performance may differ between
subtypes (Dovis et al. 2015). Therefore, including only partic-
ipants with ADHD/C and not participants with the inattentive
or hyperactive/impulsive subtype, might increase homogene-
ity in neurocognitive functioning as well. The predictive value
of neurocognitive functions for ADHD symptom severity and
overall functioning was studied taking into account baseline
symptom severity and impairment as well, respectively. Age,
gender, pharmacological treatment and study site were addi-
tionally considered as confounding variables. Taking into ac-
count limitations of earlier studies, we tested the hypotheses
that better early neurocognitive functioning would be associ-
ated with lower symptom severity and better overall function-
ing at follow-up. As the available literature did not allow us to
form specific hypotheses, we expected similar results for
ADHD symptom severity and overall functioning (i.e., better
neurocognitive functioning related to better outcomes: lower
symptom severity and better overall functioning), since over-
all functioning is highly dependent on the expression and con-
sequences of the primary symptoms (Caci et al. 2015).
Method
Participants
Participants (N = 459) with a DSM-IV-TR diagnosis of
ADHD/C aged 5–19 years were recruited from outpatient
clinics and via advertisements between 2003 and 2006 in the
Dutch part of the International Multicenter ADHD Genetics
(IMAGE) study. Six years later, subjects were invited for a
comprehensive follow-up assessment as part of the
NeuroIMAGE study (von Rhein et al. 2015). The period be-
tween baseline and follow-up assessment was on average
6.0 years (SD = 0.7) and 347 participants (75.6 %) were
retained successfully. Of these 347 participants, 226 partici-
pants participated in the neuropsychological assessment dur-
ing the IMAGE study (baseline measurement) and were
included in the current study. Results of attrition analyses are
described in the Results section.
Selection and diagnostic procedures at baseline have been
detailed previously (Müller et al. 2011a, 2011b). Briefly, in-
clusion criteria for entry at baseline were an age of 5–19 years,
Caucasian descent, IQ ≥ 70, no diagnosis of autism, epilepsy,
general learning difficulties, brain disorders, and known ge-
netic disorders, and having at least one sibling (regardless of
ADHD status). The parent and teacher Conners’ long version
(Conners et al. 1998) and Strengths and Difficulties
Questionnaire (SDQ; Goodman 1997) were used to screen
participants: T-scores ≥63 on the Conners’ ADHD subscales
L (DSM-IV Inattentive symptoms),M (DSM-IVHyperactive/
impulsive symptoms), and N (DSM-IV Total symptoms), and
scores ≥90th percentile on the SDQ Hyperactivity subscale
were considered clinical. Participants obtaining clinical scores
on any of these subscales were administered the Parental
Account of Children’s Symptoms (PACS), a semi-structured,
standardized, investigator-based interview with the parents as
informants (Taylor 1986). See Rommelse et al. (2007a); b; c)
for the algorithm used to derive each of the 18 ADHD symp-
toms as defined by the DSM-IV-TR (American Psychiatric
Association 2000). The 226 participants included in the cur-
rent study with ADHD/C at baseline came from 182 different
families. Their mean age at baseline was 11.5 years
(SD = 2.7), and 17.4 years (SD = 2.7) at follow-up, and
82.6 % was male. Regarding medication use at follow-up,
88.5 % of all participants used stimulants, 11.9 % of all par-
ticipants used atomoxetine, 4.9 % of all participants used an-
tidepressants, and 1.3 % of all participants used tranquillizers
(e.g., benzodiazepines, anxiolytics).
Outcome Measures At follow-up, ADHD total symptom se-
verity as well as inattentive and hyperactive/impulsive symp-
tom severity were assessed with the Conners’ Parent Rating
Scale–Revised: Long version (CPRS-R:L; Conners et al.
1998) scales N (DSM-IV Total symptoms; Cronbach’s
α = 0.93), L (DSM-IV Inattentive symptoms; Cronbach’s
α = 0.90) and M (DSM-IV Hyperactive/impulsive symptoms;
Cronbach’s α = 0.87), respectively. Scores on the Conners’
ADHD subscales represent combined measures of the number
(maximum 18) and severity (range 0–3) of symptoms, with
scores ranging between 0 and 54 (maximum number of symp-
toms; 18, with maximum severity; 3), or between 0 and 27
(maximum number of symptoms within one symptoms axis;
9, with maximum severity; 3), respectively. Raw scores were
used.
The Global Assessment Scale-score (K-GAS) of the Dutch
version of the Schedule for Affective Disorders and
Schizophrenia for School-Age Children - Present and
Lifetime Version (K-SADS; Kaufman et al. 1997) adminis-
tered at follow-up to both the parent and the child ≥12 years
separately, was used to measure overall functioning. This
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measure is a time-efficient and clinically relevant measure of
overall functioning. After finishing the K-SADS interview,
the interviewer rated psychological, academic and social func-
tioning. This resulted in an overall measure of the current level
of functioning ranging between 1 (worst possible level of
functioning) and 9 (best possible level of functioning;
Schorre and Vandvik 2004).
For both the K-SADS and the PACS, interviewers of the
participating centers underwent comprehensive training by a
team under the supervision of E. Taylor at the London Institute
of Psychiatry (PACS) or JB at the Donders Institute for Brain,
Cognition and Behavior, RadboudUniversityMedical Centre,
Nijmegen (K-SADS). Trained interviewers used the same
training and supervision procedures for additional inter-
viewers at the participating centers. Inter-rater agreement for
the PACS was 0.88 (range 0.71–1.00; Müller et al. 2011a) and
for the K-SADS 0.94 (ADHD), 0.89 (ODD), and 0.95 (CD;
von Rhein et al. 2015). The interviewers were trained clini-
cians (child psychiatrists, psychologists) or trained
researchers.
Predictor Variables We investigated eight domains of
neurocognitive functioning measured at baseline: working
memory, motor inhibition (the ability to stop a prepotent re-
sponse), cognitive inhibition (the ability to flexibly shift be-
tween two response options), reaction time variability, timing,
information processing speed, motor control, and intelligence.
Domains were chosen to include a broad array of
neurocognitive tasks (see Table 1) that are known to be sen-
sitive to detect differences between children with ADHD and
control children (Rommelse et al. 2008a, b; c; Rommelse et al.
2008a, b; c), and that yield enough variance in order to be
useful as predictors of differences in symptom severity and
overall functioning (Nigg et al . 2005). For each
neurocognitive domain, we performed a principal component
analysis (PCA) to optimize the number of predictor variables
and reduce error variance; a total of eight principal component
analyses thus were performed. First, we selected the most
widely used and theoretically valid independent measures
for each domain, thereby including at least two measures in
each PCAwith the exception of the domain of intelligence, for
which only one measure (based on four subtests) was avail-
able. When two measures from one task within a domain
correlated >0.85, one of the measures was excluded from the
PCA to prevent clustering of highly correlated variables.
Table 2 provides a description of the neurocognitive do-
mains and corresponding measures that were finally included
in our principal component analyses, with descriptive infor-
mation and the principal component score per measure. For
working memory, we initially included four measures. Of
these four measures, ‘number of identified targets’ (NIT)
and ‘number of identified targets in the correct order’
(NITco) correlated >0.85 with each other. Therefore, we
decided to discard NIT from the PCA, because NITco not only
captures increasing length (load), but also captures correct
order, hence offering a more valid measure of working mem-
ory (Baddeley 2012). For motor control, we initially included
the mean absolute deviation and the standard deviation of the
mean distance of two motor control measures (Pursuit and
Tracking). However, both measures of the standard deviation
correlated >0.85 with the mean absolute deviation on the cor-
responding task. As the mean absolute deviation on the task is
the most widely used measure of motor control, we decided to
discard the standard deviations of both tasks from the PCA.
The PCAwas conducted using a correlation matrix, calculated
on standardized data. Results showed one component with an
Eigenvalue >1 (cut-off value) for each domain. Principal com-
ponents were rescaled so that higher scores represent better
performance. For reaction time variability, smaller variability
was interpreted as better performance. See Table 3 for a de-
scription of group means and standard deviations of the pre-
dictor and outcome variables. Supplemental Table 1(available
online) provides correlations between baseline/follow-up be-
havioral variables (symptom severity, overall functioning and
impairment) and neurocognitive predictors.
Covariates As there is a strong relationship between baseline
behavior and behavior at follow-up, models predicting symp-
tom severity were calculated with and without baseline
ADHD symptom severity (CPRS-R:L scale N: DSM-IV
Total symptoms; Cronbach’s α = 0.85). Likewise, baseline
impairment was includedwhen predicting overall functioning.
Impairment at baseline was measured by the impairment scale
of the Strengths and Difficulties Questionnaires (SDQ;
Cronbach’s α = 0.75; Goodman 1997), reported by parents
(range 0–21). When follow-up interval was significantly re-
lated to current symptom severity, follow-up interval was in-
cluded as a covariate in further analyses. Follow-up interval
was defined as the time between baseline and follow-up mea-
surement (in years). The same procedure was followed when
overall functioning was predicted. Age and age2 (assessed at
baseline), gender, pharmacological treatment until follow-up
and study site (Amsterdam or Nijmegen) were added as co-
variates to the final models. Pharmacological treatment was
collected in terms of the cumulative intake of psychostimulants
(mean daily dose multiplied with treatment duration corrected
for age) from age of onset until the follow-up assessment using
information from pharmacy records supplemented with infor-
mation from parent questionnaires. See van Lieshout et al.
(2016) for further details.
Procedure
Testing at baseline and follow-up took place at the VU
University Amsterdam, or at the Donders Institute for Brain,
Cognition and Behaviour, Radboud University in Nijmegen,
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the Netherlands. Participants were 48 h off medication before
both baseline and follow-up assessments. All ratings of be-
havioral functioning pertained the participant’s functioning off
medication. Families were financially compensated for partic-
ipation. Informed consent was signed by all participants at
both measurements, and parents signed for all children in their
family as well. The study was approved by the national and
local ethics committees.
Statistical Analysis
In the sample of 226 children, the Stop taskwas not administered
to 9.7% of participants due to technical problems. Between 0.4–
3.1 % of data were missing for other neurocognitive predictors.
Missing value analysis (Expectation Maximization with 25 iter-
ations) for Stop Task data was performed only for participants
with at least nine out of ten neurocognitive tasks available
(n = 22). Percentage of missing data at follow-up was 2.2 %
for ADHD symptom severity measures, and 3.1 % for overall
functioning measures. All outcome variables had a normal dis-
tribution with values of skewness and kurtosis within the range
of −1 to +1, except for the K-GAS score (kurtosis = −1.20). K-
GAS-scores were normalized by applying a Van der Waerden
transformation.
To optimally correct for the familial dependency in our
data, Generalized Estimating Equation analyses (GEE) were
used with an exchangeable correlation structure. An optimal
set of predictors for (1) symptom severity and (2) overall
functioning was derived by performing a backward selection
procedure (variables deleted when p > 0.05), until an optimal
final model was composed. The mean correlation between
predictors was 0.36 (0.03 ≤ r ≤ 0.70), indicating no collinear-
ity. Analyses predicting symptom severity or impairment used
three steps: (1) Models predicting symptom severity or im-
pairment were calculated with the neurocognitive predictors
only (model 1). (2) To investigate the additional predictive
value of neurocognitive functioning over and above baseline
behavior or baseline impairment, models were calculated with
the neurocognitive predictors together with baseline symptom
severity or baseline impairment (model 2). (3) Then, models
were calculated with baseline symptom severity or baseline
impairment only, for comparison (model 3). We described
Table 2 Description of Principal Components
Neurocognitive
domain
Task Measure M SD Range
(min-max)
Component
scores
Working memory ANT visuo-spatial sequencing task Total number of identified
targets in correct order
87.81 12.20 39.0–105.0 .42
WISC/WAIS-III digit span Maximum span forwards 5.21 1.10 3.0–9.0 .41
Maximum span backwards 3.81 1.12 2.0–7.0 .45
Motor inhibition Stop task SSRT 293.87 90.60 100.0–608.1 .54
Percentage commission errors 3.64 3.54 0.0–15.1 .54
Cognitive inhibition ANT shifting attentional set, block 2 Reaction time (correctedb) (ms) 230.84 174.11 −243.7-871.4 .63
Percentage errors (correctedb) 8.86 12.55 −15.0-50.0 .63
Reaction time
variability
ANT baseline speed SDRT (correcteda, ms) 0.40 0.24 0.14–1.2 .24
ANT shifting attentional set, block 1 SDRT (correcteda, ms) 0.37 0.18 0.10–1.0 .41
Stop task SDRT go trials (correcteda, ms) 0.23 0.04 0.13–0.35 .41
Motor timing SDRT (correcteda, ms) 0.28 0.09 0.07–0.58 .43
Timing Motor timing Mean absolute deviation (ms) 273.50 146.90 49.9–741.7 .38
Time test, visual modality Percentage of deviation 21.34 13.76 2.4–63.6 .39
Time test auditory modality Percentage of deviation 24.19 14.62 4.1–69.3 .39
Information
processing speed
ANT baseline speed Reaction time (ms) 360.11 81.38 224.0–638.0 .42
ANT shifting attentional set, block 1 Reaction time (ms) 269.08 920.50 269.1–920.5 .41
Stop task Reaction time go trials (ms) 591.41 114.48 357.8–
1051.1
.36
Motor control ANT pursuit Absolute deviation left hand 5.90 2.98 2.0–15.0 .58
ANT tracking Absolute deviation left hand 2.85 1.83 0.5–8.4 .58
Intelligence WISC/WAIS-III vocabulary, similarities,
block design, picture completion
Total IQ 99.46 11.68 70.0–133.0 -
ANTAmsterdamse Neuropsychologische Taken, PCA Principal Component Analysis, SDRT Standard Deviation of Reaction Time, SSRT Stop Signal
Reaction Time, WISCWechsler Intelligence Scale Children, WAIS Wechsler Adult Intelligence Scale-third edition
a Corrected for mean reaction time
b Corrected for reaction time or errors in block 1
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differences between the models (1) and (2), by evaluating the
difference in R2.
Additional Analyses To investigate age effects, both age and
quadratic effects of age were examined. Interactions between
age and significant predictors of outcome were added to the
final models with neurocognitive functioning (model 1).
When an interaction-effect with age or age2 was significant,
the finding was further explored by testing the final model in
subsamples subdivided based on age at baseline (<12 years
and 12 > = years). The same procedure was followed for
gender. The final model of ADHD symptom severity (model
1) was reran using both inattentive and hyperactive/impulsive
symptoms as outcome measures (including baseline symptom
severity), to explore whether the model was applicable to both
symptom axes.
Sensitivity Analyses As the reliability and validity of the
CPRS-R:L is only established for children under 18 years of
age, we checked whether results of the final model for ADHD
symptom severity (model 1) were robust when tested in chil-
dren younger than 18 years. Beside possible moderating ef-
fects of age and gender, we tested possible effects of con-
founders (age, age2, gender, pharmacological treatment, study
site) on the final models.
Results
Attrition Analyses
Attrition was investigated by comparing participants success-
fully followed up (i.e., included in our analyses, N = 226) with
participants lost to follow-up from the total sample on 25
variables available at baseline (age, gender, ADHD symp-
toms, neurocognitive measures). Participants who were lost
to follow-up had higher SD (corrected for MRT) on the motor
timing task (p < 0.001) and had more commission errors on
the Stop task (p = 0.036). No other significant group differ-
ences were found (0.070 < p < 0.983).
Prediction of ADHD Symptom Severity
Follow-up interval was not related to current ADHD symptom
severity (p = 0.675). Table 4 shows the final prediction model.
Better working memory predicted lower ADHD symptom
severity, explaining 3.0 % of variance. When taking baseline
symptom severity into account, better working memory still
predicted lower ADHD symptom severity, together
explaining 11.7 % of variance. For comparison, baseline
symptom severity alone explained 10.0 % of variance.
Table 3 Descriptives of
Predictor and Outcome Variables M min max SD
Baseline Variables
CPRS-R:L Inattentive symptom severity (scale L) 18.55 2.00 27.00 5.07
CPRS-R:L Hyperactive/impulsive symptom severity (scale M) 16.73 2.00 27.00 5.39
CPRS-R:L Total symptom severity (scale N) 35.29 6.00 52.00 8.99
SDQ Impairment (parent) 11.98 0.00 21.0 3.91
Follow-up Variables
CPRS-R:L Inattentive symptom severity (scale L) 14.09 0.00 27.00 6.38
CPRS-R:L Hyperactive/impulsive symptom severity (scale M) 9.26 0.00 27.00 5.80
CPRS-R:L Total symptom severity (scale N) 23.32 0.00 52.00 11.01
K-GAS-Score 6.49 2.00 9.00 1.08
Follow-up Interval 5.85 4.40 7.68 0.65
Pharmacological treatment (cumulative intake of stimulants) 118.27 0.00 477.44 111.88
Scores of neurocognitivemeasures are component scores. ADHDAttention-Deficit/Hyperactivity DisorderCPRS
Conners’ Parent Rating Scale-Revised: Long version, K-GAS Kiddie-Global Assessment Score, SDQ Strengths
and Difficulties Questionnaire, PC Principal Component
Table 4 Final Prediction Models for Current ADHD Symptom
Severity in Children with ADHD/C
b SE p
Model 1
Working memory −1.34 0.45 0.003
R2 = 3.00 %
Model 2
Working memory −1.05 0.51 0.041
CPRS-R:L symptom severity 0.43 0.06 <0.001
R2 = 11.71 %
b is the unstandardized coefficient
ADHD Attention-deficit/hyperactivity disorder, CPRS-R:L Conners’
Parent Rating Scale-Revised: Long version
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Prediction of Overall Functioning
Follow-up interval was related to the K-GAS-score
(b = −0.29, p < 0.001) and therefore included as a covariate
in all further analyses. Table 5 shows the final prediction mod-
el. Higher reaction time variability predicted lower K-GAS-
scores, explaining 5.6 % of variance. When taking baseline
parent-reported impairment into account, higher reaction time
variability still predicted lower K-GAS-scores, together
explaining 8.6 % of variance. For comparison, baseline
parent-reported impairment alone explained 7.1 % of
variance.
Additional Analyses
Age and Gender Effects Significant neurocognitive predic-
tors for both ADHD symptom severity (workingmemory) and
overall functioning (reaction time variability) did not signifi-
cantly interact with age (b = 0.02, p = 0.882/b = 0.01,
p = 0.499 respectively), age2 (b < 0.001, p = 0.978/
b < 0.001, p = 0.621 respectively), or gender (b = −1.09,
p = 0.411/ b = −0.13, p = 0.231, respectively).
Effects of Predictors on Inattention and Hyperactivity/
ImpulsivityWorking memory (model 1) was not a significant
predictor for ADHD inattention symptom severity (p = 0.174),
but was a significant predictor for current ADHD hyperactivity/
impulsivity symptom severity; better working memory pre-
dicted lower hyperactivity/impulsivity symptom severity
(p = 0.001). R2 for the final model of hyperactivity/
impulsivity was 3.91 %.
Sensitivity Analyses
Sample < 18 years Predictors relevant in the final model
(model 1) for current ADHD symptom severity were
significant with similar relationships when tested in a subsam-
ple of children younger than 18 years (b subsample = −1.43
/β = −0.15, p = 0.040,R2 = 1.6%, versus b full sample = −1.34
/ β = −0.17; p = 0.003, R2 = 3.0 %). Taking into account that
the sample size of this subsample was substantially smaller,
these findings suggest that the results also hold when the age
group was excluded for which the CPRS-R:L was not
validated.
Covariates Findings for current ADHD symptom severity as
well as for overall functioning replicated when age or age2,
gender, pharmacological treatment, or study site were added
as covariates to the final models (model 1). Covariates were
not significant in the final models for ADHD symptom sever-
ity and overall functioning (0.068 < p < 0.830).
Discussion
The current large prospective study investigated whether a
broad array of well-defined neurocognitive measures predict-
ed dimensional outcome measures of ADHD, 6 years later, in
children and adolescents with ADHD-combined type. In sum-
mary, better working memory predicted lower symptom se-
verity 6 years later, and less reaction time variability predicted
better overall functioning. Percentage of explained variance
for the neurocognitive predictors was small (3.0–5.6 %) but
significant. Together with baseline behavior, neurocognitive
predictors remained significant, and a higher percentage of
variance was explained compared to the percentage of vari-
ance explained by the baseline behavioral measures or
neurocognitive measures alone.
The current finding that both better working memory and
less reaction time variability contribute to better outcomes is
in line with our hypothesis that better early neurocognitive
functioning is associated with a positive outcome of ADHD.
Interestingly, our finding is also consistent with the results of a
recent study in which ADHD symptoms were assessed on a
continuum both at baseline and follow-up, showing that better
working memory and less reaction time variability predicted
future ADHD symptoms and academic achievement, over and
above baseline behavioral symptoms (Sjöwall et al. 2015).
Notably, also other studies suggested that impairments in
working memory and larger reaction time variability are most
prominent of all neurocognitive functions involved in ADHD
(Castellanos and Tannock 2002; Martinussen et al. 2005;
Tamm et al. 2012). Previous studies, however, did not find
predictive value of both verbal and spatial working memory
for future ADHD status or symptoms (Biederman et al. 2009;
Coghill et al. 2014). These discrepant findings may relate to
differences between other studies and our study; e.g., smaller
sample size (Biederman et al. 2009; Coghill et al. 2014), using
dichotomous outcome measures compared to continuous
Table 5 Final Prediction Models for Current Overall Functioning in
Children with ADHD/C
b SE p
Model 1a
Reaction time variability 0.11 0.05 .018
R2 = 5.60 %
Model 2a
Reaction time variability 0.10 0.04 .030
SDQ impairment parent −0.04 0.01 .003
R2 = 8.62 %
b is the unstandardized coefficient
ADHD Attention-deficit/hyperactivity disorder, SDQ Strengths and
Difficulties Questionnaire
aModels are adjusted for follow-up interval
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measures (Biederman et al. 2009), and longer lengths of
follow-up interval (Biederman et al. 2009). Also, previous
studies measured the domain-specific aspects of phonological
loop or visuo-spatial sketchpath (e.g., digit span or arithmetic
subtests of the WISC/WAIS [Biederman et al. 2009] or visuo-
spatial working memory in a forward form [Coghill et al.
2014]). In our study, we used a component measure of verbal
(both a forward and backward condition) and visuospatial
working memory. Possibly, with such a measure, we investi-
gated a more domain-general central executive aspect of
working memory (Kofler et al. 2014), which may have greater
predictive power and may explain discrepancies in findings
from other studies. By using different measures and tasks of
working memory, we also tried to avoid a general issue re-
garding working memory, namely the debate about the exact
underlying neurocognitive function that is assessed with span
tasks (Aben et al. 2012; Cowan 2008; Davelaar 2013). Our
finding that better working memory specifically predicted
lower hyperactivity/impulsivity symptom severity, is in line
with one study showing that the performance in the domain-
general central executive aspect of working memory was sig-
nificantly related to children’s activity level, which suggests
that hyperactivity may act as a compensatory mechanism for
working memory (Rapport et al. 2009). Regarding reaction
time variability, to our knowledge, no other study investigated
this neurocognitive function as predictor for future ADHD
symptom severity or overall functioning.
Surprisingly, early inhibitory functioning and timing abili-
ties did not predict current symptom severity or overall func-
tioning. These results contrast the view that these functions act
as core deficit in ADHD (Barkley 1997; Durston et al. 2011;
Toplak et al. 2006). Furthermore, these results are inconsistent
with previous studies in our sample showing large deficits with-
in the domain of inhibitory functioning and timing (Rommelse
et al. 2008a, b; c; Rommelse et al. 2008a, b; c; Rommelse et al.
2007a, b; c). However, earlier studies confirm that inhibitory
functioning and timing abilities may not predict ADHD out-
comes (McAuley et al. 2014; van Lieshout et al. 2013). Our
data suggest that relations between neurocognitive functioning
and ADHD outcomes over time may differ between
neurocognitive functions that are thought to be closely related.
There are some alternative explanations that should be
discussed in relation to our findings. The finding that many
of our baseline neurocognitive measures did not predict future
outcomes, gives rise to the thought that the development of
neurocognitive performance may not relate to ADHD out-
comes at all, which would theoretically be of interest. In ad-
dition, it is possible that neurocognitive functioning and over-
all functioning are not evenrelated to each other at baseline
(such as ADHD and neurocognitive functioning), which
would explain that we did not find a longitudinal relationship
between most of our neurocognitive measures and overall
functioning in particular.
In this study, we addressed questions regarding age, gen-
der, pharmacological treatment, follow-up interval and study
site, to contribute to existing literature. Previous studies re-
vealed mainly negative findings on the predictive value of
early neurocognitive functions for ADHD outcomes. As brain
development is thought to be non-linear (Giedd et al. 1999),
with, for example, a developmental spurt in adolescence
(Casey et al. 2011), we expected moderating effects of age
on the relation between relevant neurocognitive predictors
andADHD outcomes. Surprisingly, our models were indepen-
dent of age. Similarly, predictive effects were independent of
gender. According to our findings, relations between both
working memory and response variability and ADHD out-
comes were not confounded by the duration of medication
taken until follow-up. Moreover the duration of medication
taken had no beneficial effect on our ADHD outcomes, as
medication use was a non-significant predictor in the models.
This finding is consistent with findings of the MTA study
showing that over 6 to 8 years, there was no advantage of
pharmacological treatment on ADHD outcomes (Molina
et al. 2009). Long-term benefits on academic and occupational
outcomes, social functioning and comorbidities are also ques-
tionable (Langberg and Becker 2012; van de Loo-Neus et al.
2011). Pharmacological treatment is one of the preferred treat-
ments in ADHD and may have adverse side effects as well.
Our results and previous findings failing to support long term
benefits of pharmacological treatment stress the importance of
more work in this important area of research. Another issue is
that follow-up interval was related to a lower K-GAS-score.
Further exploring this relationship showed us that younger
children were the ones with longer follow-up intervals; it
may thus well be possible that this finding reflects the larger
impact ADHD has on the overall functioning of younger chil-
dren. Study site was not a factor of relevance to our data.
Taken together, the predictive value of neurocognitive
functioning for ADHD outcomes is small; smaller than we
expected based on the well-established and moderate to strong
relationship between ADHD behavior and neurocognitive
functioning observed cross-sectionally. The small relationship
between baseline neurocognitive functioning and behavioral
outcomes on the long term that we found, together with earlier
findings on this topic (Coghill et al. 2014; McAuley et al.
2014; Rajendran et al. 2013a, b; van Lieshout et al. 2013)
shows that neurocognitive functioning may not be seen as
protective or a risk factor for longer term behavioral outcomes.
These findings clearly indicate that further research is needed
to understand the role or neurocognitive functioning in
ADHD, for example by setting up longitudinal studies that
look into more complex interactions of neurocognitive func-
tioning with genetics and environment (e.g., family environ-
ment, peer group influences) and look at more than symptom
outcome and functioning such as social behavior and self-
esteem (Savitz et al. 2007). Based on our findings, it may be
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suggested that working memory and variability in responding
are the promising neurocognitive measures that can contribute
to such multimodal prediction models.
Clinically, our findings indicate that although working
memory and variability in reaction time are independently
predictive of ADHD outcomes, these effects are of such small
magnitude that our findings are yet of little relevance for reli-
ably establishing prognosis. This means that we are not able to
predict which children with ADHDwill improve on their level
of behavioral symptoms and/or impairment based on their
neurocognitive performance at an earlier time point. Our find-
ings do not rule out the possibility that neurocognitive profil-
ing to establish current strengths and weaknesses still may be
of relevance for improving and supporting (school/occupa-
tional) functioning at the current moment, or to help under-
stand and explain certain behavioral problems or impairments.
Some limitations should be noted. First, some aspects of
our sample limit generalization to the population, including
our exclusive focus on participants with the combined type of
ADHD (Lara et al. 2009), the limited representation of girls in
our sample and the inclusion of Caucasian individuals.
Second, we did not verify medication use with the participant,
which may have resulted in a less than optimal estimation of
medication use in reality. Third, although we did include a
broad array of neurocognitive functions, we were not able to
include all neurocognitive domains currently regarded impor-
tant in ADHD, such as reward related neurocognitive func-
tions. Our findings thus cannot be generalized to other
neurocognitive domains. Fourth, we have chosen to use
performance-based measures of neurocognitive functioning.
Rater-based measures of neurocognitive functioning may
show higher predictive value, as these measures may be more
closely related to behavior and investigate capacities in more
unstructured situations, which may better mirror ‘real-life’
functioning. Fifth, for the investigation of the value of
neurocognitive functioning over and above baseline behavior,
we used the exact same measures for baseline symptom se-
verity and follow-up symptom severity. This may partly ex-
plain the higher percentage of explained variance for baseline
symptoms compared to neurocognitive functioning.
To further disentangle the complex relation between
neurocognitive functioning and ADHD symptoms, future
studies could take into account both neurocognitive function-
ing at baseline and at follow-up, in order to look at the relation
between neurocognitive development over time and the
course of ADHD. In addition, a person-based analysis in
which neurocognitive profiles within one person are investi-
gated might shed more light on this issue as well. Patterns of
neurocognitive performance within one personmight be better
suited to predict future outcomes such as symptom severity
and overall functioning. Such approaches might enable us to
further understand the complexity of the development of be-
havior and understanding mechanisms of recovery from
problematic behavior. Adding key concepts in ADHD such
as reward processing may add to a more complete understand-
ing of ADHD.
In conclusion, using a broad array of early neurocognitive
functions to predict current ADHD symptom severity and
overall functioning, we found only little evidence for the hy-
pothesis that a stronger neurocognitive profile (better working
memory, smaller reaction time variability) predicts better out-
come. Our findings challenge the role of neurocognitive func-
tioning in the long term outcome of ADHD.
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